Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Interest Expenses (2017 - 2025)

Historic Interest Expenses for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $205700.0.

  • Selectis Health's Interest Expenses fell 5670.66% to $205700.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 4390.26%. This contributed to the annual value of $2.0 million for FY2024, which is 583.67% down from last year.
  • Selectis Health's Interest Expenses amounted to $205700.0 in Q3 2025, which was down 5670.66% from $225991.0 recorded in Q2 2025.
  • Over the past 5 years, Selectis Health's Interest Expenses peaked at $817353.0 during Q4 2021, and registered a low of $205700.0 during Q3 2025.
  • For the 5-year period, Selectis Health's Interest Expenses averaged around $522322.8, with its median value being $542667.0 (2025).
  • Its Interest Expenses has fluctuated over the past 5 years, first soared by 6983.79% in 2023, then plummeted by 6141.58% in 2025.
  • Selectis Health's Interest Expenses (Quarter) stood at $817353.0 in 2021, then fell by 3.03% to $792604.0 in 2022, then decreased by 14.23% to $679840.0 in 2023, then crashed by 47.68% to $355717.0 in 2024, then plummeted by 42.17% to $205700.0 in 2025.
  • Its last three reported values are $205700.0 in Q3 2025, $225991.0 for Q2 2025, and $542667.0 during Q1 2025.